Categories: LATEST NEWS

Analog Devices and LifeQ Collaborate to Improve Effectiveness of Body Monitoring Devices in Health Management

Analog Devices, Inc. (ADI) today announced a collaboration with LifeQ to develop technology that will make it possible for non-invasive body monitoring devices to provide highly accurate physiological data that currently is only available through the use of expensive, invasive and hard-to-access equipment. By combining the market-leading engineering and innovation of Analog Devices with the unique biomathematical capabilities of LifeQ, the two companies plan to design sensors that enable personalized, continuous and accurate tracking of physiological parameters such as heart rate, sleep phases, sleep quality, blood lactate, 24-hour calorie intake as well as stress markers such as salivary cortisol. Monitoring this type of data can increase early detection of emergency conditions and diseases in at-risk patients.

“The development of smart wearable sensors is essential to supercharge the next generation of non-invasive body monitoring solutions,” said James Doscher, general manager, Industrial and Business Healthcare Group, Analog Devices. “ADI offers the semiconductor expertise and LifeQ provides the bio-mathematical understanding needed to develop sensors that can make body monitoring devices even more effective in preventing, predicting and managing diseases. This, in turn, will impact how doctors and patients share information, interact, and make decisions about patient care. Patients can have greater access to vital data about their own bodies and be more involved in their overall health and wellness.”

“LifeQ’s collaboration with ADI will enable sensor solutions that meet a higher and wider standard, including new industry benchmarks such as the latest Android Wear requirements,” said Riaan Conradie, co-founder and chief operating officer, LifeQ. “Our goal is to deliver high-value physiological data to ecosystem partners who are serving consumer lifestyle, corporate wellness and health insurance markets.”

ADI’s comprehensive portfolio of linear, mixed-signal, MEMS (microelectromechanical systems) and digital processing technologies are used in healthcare diagnostics, clinical monitoring equipment, life science and medical instrumentation, and health and wellness device designs.

With its world leading computational systems biology expertise, LifeQ ensures a unique approach to the construction and acquisition of information from bio-sensors. Combined with the patented LifeQ bio-mathematical engine, a range of physiological measures that are currently inaccessible, costly and invasive are now available both through wearable devices and via LifeQ’s API.

Liat

Recent Posts

Quantum Art Raises $100 Million in Series A Round to Drive Scalable, Multi-Core Quantum Computing

Funding will support Quantum Art in reaching a 1,000-qubit commercial platform and global expansion Quantum…

2 days ago

Hud Ships First Runtime Code Sensor to Bring Production Reality to Code Generation

Hud automatically captures live service and function-level data from production- providing the missing context for…

2 days ago

Port Raises $100M Series C to Power Agentic Engineering Platform

General Atlantic leads round valuing company at $800M as Port tackles the 90% of developer…

2 days ago

Prime Security Raises $20M to Transform Product Security with the First Agentic Security Architect

Prime’s new platform accelerates development with automated security reviews and full visibility into design-level risks…

3 days ago

Safebooks AI Raises $15 Million to Automate Revenue Data Integrity for Enterprise Finance Teams

Safebooks Inc., the pioneer in Financial Data Governance, today announced its emergence from stealth and…

3 days ago

NVIDIA and AWS Expand Full-Stack Partnership, Providing the Secure, High-Performance Compute Platform Vital for Future Innovation

AWS integrates NVIDIA NVLink Fusion into its custom silicon, including the next-generation Tranium4 chip, Graviton…

1 week ago